Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b) program.
Literal federal measure citations: S.705
2025 · 4th Quarter (Oct 1 - Dec 31)
GLAXOSMITHKLINE LLC
Filed by LMH STRATEGIC SOLUTIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 12, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- LMH STRATEGIC SOLUTIONS
- Client
- GLAXOSMITHKLINE LLC
- Filing UUID
- 5afde9cc-87fa-4028-ae28-2de655ac7e41
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Literal federal measure citations: S.705
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.